We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3092:TSEZOZO, Inc. Analysis

Data as of 2026-03-14 - not real-time

NT$32.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The 20‑day moving average sits above the 50‑day average, confirming a bullish bias. The price is comfortably above the long‑term average, reinforcing the upward trend. Momentum indicators show a neutral to slightly overbought reading, with the RSI hovering in the mid‑range. The MACD histogram has turned negative, suggesting a short‑term weakening momentum. Volume has been picking up, supporting the price advance. However, the stock exhibits very high recent price swings, indicating elevated volatility.
Fundamentally, the company is reporting negative margins across the board and a substantial debt load relative to equity. Cash generation is negative, and free cash flow remains in the red, raising concerns about sustainability. The price‑to‑book multiple is above one, but earnings are absent, making valuation challenging. No dividend is paid, so income‑focused investors have little appeal. Given the mix of bullish technical signals and weak fundamentals, the outlook is mixed. Investors should weigh the short‑term price momentum against the long‑term earnings risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical bullish bias with price above short‑term averages
  • Increasing volume supporting momentum
  • Negative MACD histogram warning of near‑term pullback

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative earnings and cash flow
  • High debt burden limiting flexibility
  • Elevated volatility could erode gains

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Fundamental deterioration with ongoing losses
  • Lack of dividend and earnings recovery outlook
  • Sector competitive pressures and debt risk

Key Metrics & Analysis

Financial Health

Revenue Growth-6.90%
Profit Margin-33.40%
ROE-32.84%
ROA-6.98%
Debt/Equity128.36
P/B Ratio2.4
Op. Cash FlowNT$-358105984
Free Cash FlowNT$-677743744
Industry P/E29.1

Technical Analysis

TrendBullish
RSI57.7
SupportNT$22.40
ResistanceNT$40.50
MA 20NT$29.72
MA 50NT$27.01
MA 200NT$19.52
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.52
Volatility85.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.